# Chris Hart

> Chris Hart is a computational biologist, Creyon Bio co-founder and founding president and CEO, and Chief Data and AI Officer at ProQR. He previously led data science and AI/ML in Eli Lilly’s Genetic Medicines team and built the functional genomics group at Ionis Pharmaceuticals. His career also includes academic research, teaching, and science policy.

- **Role:** Chief Data and AI Officer at ProQR Therapeutics
- **Organizations:** ProQR Therapeutics, Eli Lilly and Company, Creyon Bio, Ionis Pharmaceuticals, New College of Florida, Lovelace Respiratory Research Institute, Science and Technology Policy Institute
- **Education:** B.S., Siena College, Ph.D.; biology and computer science applications in biotechnology, California Institute of Technology, Postdoctoral training, Yale University
- **Known for:** Built and led the functional genomics group at Ionis Pharmaceuticals., Co-founded Creyon Bio and served as its founding president and CEO., Led Creyon through its early financing, hiring, and expansion into laboratory spaces in San Diego, North Carolina, and India.

## Career timeline

- **—** — Worked at the Science and Technology Policy Institute advising the White House Office of Science and Technology Policy.
- **—** — Researched computational biology at Lovelace Respiratory Research Institute and researched and taught bioinformatics as a tenure-track faculty member at New College of Florida.
- **Before October 2019** — Spent seven years at Ionis Pharmaceuticals, building and leading functional genomics; held the title Executive Director of Functional Genomics.
- **2019-10** — Incorporated Creyon Bio and became its founding president and CEO.
- **2020** — Built the first employee team at Creyon.
- **2022-03** — Creyon launched publicly with more than $40 million in seed and Series A financing.
- **2024-10** — Announced departure from Creyon on its fifth anniversary.
- **Before September 2026** — Served as Vice President of Data Science and AI/ML in Eli Lilly’s Genetic Medicines team.
- **2026-09** — Appointed Chief Data and AI Officer at ProQR.

## Achievements

- Built and led the functional genomics group at Ionis Pharmaceuticals.
- Co-founded Creyon Bio and served as its founding president and CEO.
- Led Creyon through its early financing, hiring, and expansion into laboratory spaces in San Diego, North Carolina, and India.
- Joined ProQR’s management team as Chief Data and AI Officer in September 2026.

## Latest updates

- **2026-09** — ProQR announced Hart’s appointment as Chief Data and AI Officer on September 23, 2026.
- **2024-10** — Hart publicly announced that he had parted ways with Creyon Bio.

## Links

- LinkedIn: https://www.linkedin.com/in/christopherehart/

---

Profile page: https://yespress.io/chris-hart
Published by YesPress — https://yespress.io
Last updated: 2026-10-15